Advertisement

Efficient Transfection of Primary Cells Relevant for Cardiovascular Research by nucleofection®

  • Corinna Thiel
  • Michael Nix
Part of the Methods in Molecular Medicine book series (MIMM, volume 129)

Abstract

Cell types that are important for cardiovascular research, e.g., cardiomyocytes, endothelial cells, or adult stem cells, are often hard to isolate, culture, and transfect. Low-transfection efficiencies are a major limitation because, in many cases, results achieved with surrogate model cell lines, if any at all are available for the primary cell type of interest, do not reflect the situation in the primary cell. We have demonstrated that unprecedented transfection results are achieved with primary cells when novel electroporation conditions are combined with a treatment of the cells in specific solutions that help stabilize the cells in the electrical field. This led to the development of the new proprietary transfection technology nucleofection®. Nucleofection has proved to be successfully applicable to a variety of primary cells and other hard-to-transfect cell lines, and, thus, opens unique perspectives for novel experimental setups as therapeutic strategies. Herein we present protocols for the efficient nucleofection of human umbilical vein endothelial cells, human coronary artery endothelial cells, smooth muscle cells (e.g., pig vascular smooth muscle cells), neonatal rat cardiomyocytes, and human mesenchymal stem cells and depict some results obtained with such transfected cells.

Key Words

Transfection nucleofection® cardiovascular research primary cells endothelial cells cardiomyocytes smooth muscle cells stem cells 

References

  1. 1.
    Jiang, Y., Jahagirdar, B. N., Reinhardt, R. L., et al. (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41–49.CrossRefPubMedGoogle Scholar
  2. 2.
    Huttmann, A., Li, C. L., and Duhrsen, U. (2003) Bone marrow-derived stem cells and “plasticity”. Ann. Hematol. 82, 599–604.CrossRefPubMedGoogle Scholar
  3. 3.
    Haleem-Smith, H., Derfoul, A., Okafor, C., et al. (2005) Optimization of high-efficiency transfection of adult human mesenchymal stem cells in vitro. Mol. Biotechnology 30, 9–20.CrossRefGoogle Scholar
  4. 4.
    Tuli, R., Tuli, S., Nandi, S., et al. (2003) TGF-beta-mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and MAP kinase and wnt signalling crosstalk. J. Biol. Chem. 278, 41,227–41,236.CrossRefPubMedGoogle Scholar
  5. 5.
    Baksh, D., Song, L., and Tuan, R. S. (2004) Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J. Cell. Mol. Med. 8, 301–316.CrossRefPubMedGoogle Scholar
  6. 6.
    Hamm, A., Krott, N., Breibach, I., Blindt, R., and Bosserhoff, A. K. (2002) Efficient transfection method for primary cells. Tissue Eng. 8, 235–245.CrossRefPubMedGoogle Scholar
  7. 7.
    Barlic, J., McDermott, D. H., Merrell, M. N., Gonzales, J., Via, L. E., and Murphy, P. M. (2004) Interleukin (IL)-15 and IL-2 reciprocally regulate expression of the chemokine receptor CX3CR1 through selective NFAT1-and NFAT2-dependent mechanisms. J. Biol. Chem. 279, 48,520–48,534.CrossRefPubMedGoogle Scholar
  8. 8.
    Lin, B., Kolluri, S. K., Lin, F., et al. (2004) Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 116, 527–540.CrossRefPubMedGoogle Scholar
  9. 9.
    Harriague, J. and Bismuth, G. (2002) Imaging antigen-induced P13K activation in T cells. Nat. Immunol. 3, 1090–1096.CrossRefPubMedGoogle Scholar
  10. 10.
    Lakshmipathy, U., Pelacho, B., Sudo, K., et al. (2004) Efficient transfection of embryonic and adult stem cells. Stem Cells 22, 531–543.CrossRefPubMedGoogle Scholar
  11. 11.
    Nagahata, T., Sato, T., Tomura, A., Onda, M., Nishikawa, K., and Emi, M. (2005) Identification of RAI3 as a therapeutic target for breast cancer. Endocr. Relat. Cancer 12, 65–73.CrossRefPubMedGoogle Scholar
  12. 12.
    Lehrman, S. (1999) Virus treatment questioned after gene therapy death. Nature 401, 517, 518.CrossRefPubMedGoogle Scholar
  13. 13.
    Hannah, M. J., Hume, A. N., Arribas, M., et al. (2003) Weibel-Palade bodies recruit Rab27 by a content-driven, maturation dependent mechanism that is independent of cell type. J. Cell. Sci. 116, 3939–3948.CrossRefPubMedGoogle Scholar
  14. 14.
    Peister, A., Mellad, J. A., Wang, M., Tucker, H. A., and Prockop, D. J. (2004) Stable transfection of MSCs by electroporation. Gene Therapy 11, 224–228.CrossRefPubMedGoogle Scholar
  15. 15.
    Potapova, I., Plotnikov, A., Lu, Z., et al. (2004) Human mesenchymal stem cells as a gene delivery system to create cardiac pacemakers. Circ. Res. 94, 952–959.CrossRefPubMedGoogle Scholar
  16. 16.
    Chamley-Campell, J., Campell, G., and Ross, R. (1979) The smooth muscle cell in culture. Physiol. Rev. 59, 1–61.Google Scholar
  17. 17.
    Bergmann, M. W., Loser, P., Dietz, R., and von Harsdorf, R. (2001) Effect of NF-κB Inhibition on TNFα-induced apoptosis and downstream pathways in cardiomyocytes. J. Mol. Cell Cardiol. 33, 1223–1232.CrossRefPubMedGoogle Scholar
  18. 18.
    von Harsdorf, R., Li, P. F., and Dietz, R. (1999) Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation 99, 2934–2941.Google Scholar

Copyright information

© Humana Press Inc. 2006

Authors and Affiliations

  • Corinna Thiel
    • 1
  • Michael Nix
    • 1
  1. 1.amaxa biosysytemsCologneGermany

Personalised recommendations